Another systematic review found that these patients also exhibited higher B-type natriuretic peptide (BNP) levels than patients with nonsevere COVID19, while there was no significant differences in levels of another cardiac injury-specific biomarker, troponin (Zhao et al., 2021b). Here, NPPB is linked to COVID-19.